Foldi J, Blenman KRM, Marczyk M, Gunasekharan V, et al. Peripheral blood immune parameters, response, and adverse events after
neoadjuvant chemotherapy plus durvalumab in early-stage triple-negative breast
cancer. Breast Cancer Res Treat 2024 Jul 13. doi: 10.1007/s10549-024-07426.
PMID: 39002068
|